Report: Global Pandemic Increased Poverty in Africa

Nairo­bi —  The glob­al pan­dem­ic has pushed more than 55 mil­lion Africans into extreme pover­ty and reversed two decades of hard work in pover­ty reduc­tion on the con­ti­nent. The Eco­nom­ic Report on Africa for 2021 blamed the grow­ing pover­ty on job loss­es, reduced income and the inabil­i­ty of house­holds to man­age the risks In a 150-page…

Family death from nursing shortage inspires African-native to earn Miami degree — Journal-News

It was a fam­i­ly tragedy that first led her to con­sid­er nurs­ing as a career.A rel­a­tive in her native African coun­try died while in an under-staffed hos­pi­tal, Addae said, with only one nurse for every 50 patients.“I vowed to become a nurse to care for the sick,” said Addae, a devout Chris­t­ian. “I am a woman of faith.”Earning a degree while rais­ing four young chil­dren requires much, she said. So, she often turns to one of her favorite Bible passages.“I can do all things through Christ who strength­ens me. When the going gets tough, I just talk to my God.”Addae’s per­se­ver­ance of han­dling both moth­er­hood times four and under­grad­u­ate class­es drew both the atten­tion of and praise of Mia­mi Uni­ver­si­ty Hamil­ton professors.“I remem­ber bawl­ing my eyes out one day when I was hav­ing a con­ver­sa­tion with Mia­mi Pro­fes­sor Dr. Eyad Mus­sallem because I thought I was going to fail a course,” Addae said. “He encour­aged and believed in me when I felt I couldn’t find the strength to car­ry on.”Addae “is an excel­lent stu­dent who is always will­ing to vol­un­teer to help oth­er stu­dents and goes above and beyond what is asked of her in the class­room,” said Tri­cia Neu, assis­tant pro­fes­sor of Nurs­ing and direc­tor of the FNP track. “We are so excit­ed to have her in our grad program.”Addae wasn’t sur­prised by the aca­d­e­m­ic assis­tance or high qual­i­ty of it region­al nurs­ing professors.“I decid­ed to enroll at Mia­mi Uni­ver­si­ty Region­als because of its out­stand­ing aca­d­e­m­ic reputation.”And now she is also set­ting her sights on smash­ing a gen­der stereo­type held by some fam­i­ly mem­bers in her old country.“Becoming a nurse prac­ti­tion­er will allow me to become the first woman among my sib­lings to pur­sue (an advanced degree),” she said. “I’ll break the stereo­type that only men can achieve high­er aca­d­e­m­ic suc­cess in my family.”

Tunisia is sliding back into authoritarianism. Here’s what the US should do.

Nine long months have passed since the start of the slow-motion coup in Tunisia, a coun­try that, until recent­ly, offered one of the best hopes for democ­ra­ti­za­tion in the Mid­dle East. After shut­ter­ing the par­lia­ment with tanks in July, Pres­i­dent Kais Saied has sus­pend­ed the con­sti­tu­tion and dis­solved the Supreme Judi­cial Coun­cil. In per­haps the most disturbing…

Seeking Covid Pills, Poor Nations Fear Repeat of AIDS Crisis

The antivi­ral pills, plen­ti­ful in the Unit­ed States, are scarce over­seas. Health groups and the White House want to expand access but face obsta­cles that evoke the H.I.V. epi­dem­ic. WASHINGTON — A dev­as­tat­ing virus was lay­ing waste to nations that lacked med­i­cines avail­able to Amer­i­cans. The pills were patent­ed and pricey. Poor coun­tries lacked refrigeration…

Harvard Creates Fund to Redress Its Ties to Slavery

Har­vard Uni­ver­si­ty is com­mit­ting $100 mil­lion to study and redress its ties to slav­ery, the university’s pres­i­dent announced Tues­day, and with that mon­ey will cre­ate an endowed “Lega­cy of Slav­ery Fund,” which will con­tin­ue research­ing and memo­ri­al­iz­ing that his­to­ry, work­ing with descen­dants of Black and Native Amer­i­can peo­ple enslaved at Har­vard, as well as their…

Widespread population immunity of Covid-19 observed in South Africa before Omicron wave

1. Wide­spread under­ly­ing SARS-CoV­‑2 seropos­i­tiv­i­ty was observed in Gaut­eng province, South Africa, before the omi­cron wave.
2. Epi­demi­o­log­ic data demon­strat­ed a decou­pling of hos­pi­tal­iza­tions and deaths from infec­tions while omi­cron was circulating.
Evi­dence Rat­ing Lev­el: 2 (Good)
Study Run­down: The Omi­cron vari­ant was first iden­ti­fied in Novem­ber 2021 in Gaut­eng province, South Africa, and was des­ig­nat­ed as a vari­ant of con­cern due to its pre­dict­ed high trans­mis­si­bil­i­ty and its poten­tial to evade immu­ni­ty from neu­tral­iz­ing anti­bod­ies induced by vac­ci­na­tion or nat­ur­al infec­tion with wild-type virus. The omi­cron vari­ant out­com­pet­ed the delta vari­ant in Gaut­eng and was respon­si­ble for 98.4% of the cas­es sequenced in South Africa in Decem­ber 2021, and a pri­or pop­u­la­tion-wide sero­epi­de­mi­o­log­ic study demon­strate that 19.1% of the pop­u­la­tion was seropos­i­tive for Covid-19. How­ev­er, there is a gap in knowl­edge as to under­stand­ing the sero­preva­lence of Covid-19 before the omi­cron wave. This study found that there was wide­spread under­ly­ing SARS-CoV­‑2 seropos­i­tiv­i­ty in Gaut­eng before the omi­cron-dom­i­nant wave of Covid-19. This study was lim­it­ed by changes in the fre­quen­cy of test­ing over time which lim­it­ed head-to-head com­par­isons of case num­bers across waves, and the fourth omi­cron wave had not ful­ly sub­sided at the time of this analy­sis, which will result in a lag in the report­ing of data such as hos­pi­tal­iza­tions and deaths attrib­ut­able to this wave. Nev­er­the­less, these study’s find­ings are sig­nif­i­cant, as they demon­strate that there was wide­spread seropos­i­tiv­i­ty of Covid-19 in Gaut­eng pri­or to the omi­cron wave and that there was a decou­pling of hos­pi­tal­iza­tions and deaths from infec­tions while omi­cron was circulating.
Click to read the study in NEJM
Rel­e­vant Read­ing: Omi­cron — Decou­pling Infec­tion from Severe Disease
In-Depth [sero­epi­de­mi­o­log­ic sur­vey]: This sero­epi­de­mi­o­log­ic sur­vey was con­duct­ed from Octo­ber to Decem­ber 2021 in Gaut­eng province, South Africa, to deter­mine the sero­preva­lence of SARS-CoV­‑2 IgG, obtain­ing sam­ples from 7010 par­tic­i­pants, of whom 18.8% had received a Covid-19 vac­cine. Patients who live in the Gaut­eng province and were able to pro­vide writ­ten informed con­sent were eli­gi­ble for the study. Patients who resided out­side of the stud­ied province or declined to par­tic­i­pate were exclud­ed from the study. The pri­ma­ry out­come mea­sured was sero­preva­lence mea­sured with dried-blood-spot sam­ples and test­ed for IgG against SARS-CoV­‑2 spike pro­tein and nucle­o­cap­sid pro­tein. Out­comes in the pri­ma­ry analy­sis were assessed via unad­just­ed, uni­vari­able analy­ses for each risk fac­tor with gen­er­al­ized lin­ear mod­els with a log link to esti­mate risk ratios. Based on the analy­sis, the sero­preva­lence of SARS-CoV­‑2 IgG ranged from 56.2% among chil­dren younger than 12 years (95% Con­fi­dence Inter­val [CI], 52.6 to 59.7) to 79.7% among adults old­er than 50 years of age (95% CI, 77.6 to 81.5). 93.1% of vac­ci­nat­ed par­tic­i­pants were seropos­i­tive for SARS-CoV­‑2 while 68.4% of unvac­ci­nat­ed par­tic­i­pants were seropos­i­tive. Epi­demi­o­log­ic data also demon­strat­ed that the inci­dence of Covid-19 infec­tion increased and sub­se­quent­ly decreased more rapid­ly dur­ing the omi­cron wave than it had dur­ing the three pre­vi­ous waves. The inci­dence of infec­tion was decou­pled from the inci­dences of hos­pi­tal­iza­tion, record­ed death, and excess death dur­ing the fourth wave, as com­pared to the pro­por­tions seen in the pre­vi­ous three waves. Over­all, this study demon­strat­ed that there was wide­spread Covid-19 seropos­i­tiv­i­ty in the Gaut­eng province of South Africa before the omi­cron wave, show­ing that there was a decou­pling of hos­pi­tal­iza­tions and deaths from Covid-19 infec­tions while the omi­cron vari­ant was still circulating.
Image: PD
©2022 2 Minute Med­i­cine, Inc. All rights reserved. No works may be repro­duced with­out expressed writ­ten con­sent from 2 Minute Med­i­cine, Inc. Inquire about licens­ing here. No arti­cle should be con­strued as med­ical advice and is not intend­ed as such by the authors or by 2 Minute Med­i­cine, Inc.